To report the long-term results of the ARO @-@ randomized trial comparing hyperfractionated accelerated chemoradiation with mitomycin C/@-fluorouracil ( C-HART ) with hyperfractionated accelerated radiation therapy ( HART ) alone in locally advanced head and neck cancer .